| Literature DB >> 30274435 |
Trung T Trinh1, Linh D N Nguyen2, Trung V Nguyen3,4, Chuong X Tran5, An V Le6, Hao V Nguyen7,8, Karoline Assig9, Sabine Lichtenegger10, Gabriel E Wagner11, Cuong D Do12, Ivo Steinmetz13,14.
Abstract
The first cases of human melioidosis were described in Vietnam in the 1920s, almost a century ago. It was in Vietnam in the thirties that the saprophytic nature of B. pseudomallei was first recognized. Although a significant number of French and U.S. soldiers acquired the disease during the Vietnam wars, indigenous cases in the Vietnamese population were only sporadically reported over many decades. After reunification in 1975, only two retrospective studies reported relatively small numbers of indigenous cases from single tertiary care hospitals located in the biggest cities in the South and the North, respectively. Studies from provincial hospitals throughout the country were missing until the Research Network on Melioidosis and Burkholderia pseudomallei (RENOMAB) project started in 2014. From then on seminars, workshops, and national scientific conferences on melioidosis have been conducted to raise awareness among physicians and clinical laboratory staff. This led to the recognition of a significant number of cases in at least 36 hospitals in 26 provinces and cities throughout Vietnam. Although a widespread distribution of melioidosis has now been documented, there are still challenges to understand the true epidemiology of the disease. Establishment of national guidelines for diagnosis, management, and reporting of the disease together with more investigations on animal melioidosis, genomic diversity of B. pseudomallei and its environmental distribution are required.Entities:
Keywords: Burkholderia pseudomallei; Vietnam; animal; environment; melioidosis; public awareness
Year: 2018 PMID: 30274435 PMCID: PMC6073866 DOI: 10.3390/tropicalmed3020039
Source DB: PubMed Journal: Trop Med Infect Dis ISSN: 2414-6366
Number of indigenous Vietnamese patients with melioidosis and the respective outcome reported over time in medical journals.
| Year of Reporting | No. of Patient | No. of Recoveries a | No. of Deaths | No. of Unknown Outcome | Reference |
|---|---|---|---|---|---|
| 1926 | 1 | 0 | 1 | 0 | [ |
| 1949 | 9 | 5 | 0 | 4 | [ |
| 1958 | 1 | 0 | 1 | 0 | [ |
| 1967 | 1 | 1 | 0 | 0 | [ |
| 1995 | 7 | 1 | 6 | 0 | [ |
| 1990 | 1 | 1 | 0 | 0 | [ |
| 1999 | 9 | 0 | 0 | 9 | [ |
| 2008 | 55 | 32 | 17 | 6 | [ |
| 2018 | 70 | 30 | 18 | 22 | [ |
a Recovery during the study.
Figure 1Location of hospitals taking part in the RENOMAB project and reporting culture-confirmed melioidosis cases. All of the B. pseudomallei strains were sent to the reference laboratory at the Institute of Microbiology and Biotechnology, Vietnam National University, Hanoi. B. pseudomallei identification of bacterial strains was confirmed by using either recA sequence analysis or B. pseudomallei-specific TTSS1 real-time PCR assay [28]. Border lines of provinces or cities are shown. The color indicates the number of hospitals within the province or city that reported cases of melioidosis. Geographic map was constructed by the MapInfo 7.8 (MapInfo, Troy, NY, USA).